StockData

NuCana plc (NCNA) stock

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30
$0.83−0.06 (-6.42%)

Close on Nov 18, 2026Market cap $3.47MP/E –Yield –

NuCana revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for NuCana

NuCana has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NuCana figures

See a number that looks wrong?